Most of the PCPs in this study (88.9%) agree that insulin therapy should be initiated depending on the degree of hyperglycemia or HbA1c levels, especially if the patient was on a maximum dose of oral antihyperglycemic medications with an HbA1c > 7%. This evidence concerns the gene INS and Hyperglycemia.